Skip to main content
. 2022 Apr 27;12:889159. doi: 10.3389/fonc.2022.889159

Figure 8.

Figure 8

ECM1 promotes in vivo CRC tumor growth. (A–C) ECM1 enhanced in vivo tumor growth, as determined through measurements of tumor weight and volume at 25 days post-implantation. (D–G) ECM1, Vimentin, and E-cadherin expression levels in xenograft tumors were assessed via Western blotting. Data are means ± SD (**P < 0.01, ***P < 0.001)